• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多癌种分析非致癌基因对 DNA 修复的依赖性。

Pan-cancer analysis of non-oncogene addiction to DNA repair.

机构信息

Robotic Radiosurgery Center, International Cancer Center, San José, Costa Rica.

Section of Genetics and Biotechnology, School of Biology, University of Costa Rica, San Pedro, San José, Costa Rica.

出版信息

Sci Rep. 2021 Dec 1;11(1):23264. doi: 10.1038/s41598-021-02773-3.

DOI:10.1038/s41598-021-02773-3
PMID:34853396
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8636604/
Abstract

Cancer cells usually depend on the aberrant function of one or few driver genes to initiate and promote their malignancy, an attribute known as oncogene addiction. However, cancer cells might become dependent on the normal cellular functions of certain genes that are not oncogenes but ensure cell survival (non-oncogene addiction). The downregulation or silencing of DNA repair genes and the consequent genetic and epigenetic instability is key to promote malignancy, but the activation of the DNA-damage response (DDR) has been shown to become a type of non-oncogene addiction that critically supports tumour survival. In the present study, a systematic evaluation of DNA repair addiction at the pan-cancer level was performed using data derived from The Cancer Dependency Map and The Cancer Genome Atlas (TCGA). From 241 DDR genes, 59 were identified as commonly essential in cancer cell lines. However, large differences were observed in terms of dependency scores in 423 cell lines and transcriptomic alterations across 18 cancer types. Among these 59 commonly essential genes, 14 genes were exclusively associated with better overall patient survival and 19 with worse overall survival. Notably, a specific molecular signature among the latter, characterized by DDR genes like UBE2T, RFC4, POLQ, BRIP1, and H2AFX showing the weakest dependency scores, but significant upregulation was strongly associated with worse survival. The present study supports the existence and importance of non-oncogenic addiction to DNA repair in cancer and may facilitate the identification of prognostic biomarkers and therapeutic opportunities.

摘要

癌细胞通常依赖于一个或少数几个驱动基因的异常功能来启动和促进其恶性转化,这种特性被称为致癌基因成瘾。然而,癌细胞可能会依赖于某些非致癌基因的正常细胞功能来维持生存(非致癌基因成瘾)。DNA 修复基因的下调或沉默以及随之而来的遗传和表观遗传不稳定性是促进恶性转化的关键,但 DNA 损伤反应 (DDR) 的激活已被证明成为一种非致癌基因成瘾,这对肿瘤的存活至关重要。在本研究中,使用来自癌症依赖图谱(Cancer Dependency Map)和癌症基因组图谱(TCGA)的数据,在泛癌水平上对 DNA 修复成瘾进行了系统评估。从 241 个 DDR 基因中,鉴定出 59 个在癌细胞系中普遍必需。然而,在 423 个细胞系中的依赖性评分和 18 种癌症类型中的转录组改变方面,观察到了很大的差异。在这 59 个普遍必需的基因中,有 14 个基因与患者总体生存情况更好相关,19 个基因与总体生存情况更差相关。值得注意的是,在后一组中,有一个特定的分子特征,其特征是 DDR 基因如 UBE2T、RFC4、POLQ、BRIP1 和 H2AFX 的依赖性评分最低,但显著上调与较差的生存强烈相关。本研究支持了非致癌性 DNA 修复成瘾在癌症中的存在和重要性,并可能有助于鉴定预后生物标志物和治疗机会。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a45/8636604/69ab5fde9e6a/41598_2021_2773_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a45/8636604/e044502cc340/41598_2021_2773_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a45/8636604/1a4ae0e50e56/41598_2021_2773_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a45/8636604/0fbb656c9dcb/41598_2021_2773_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a45/8636604/b747293057c2/41598_2021_2773_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a45/8636604/c4d618c50100/41598_2021_2773_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a45/8636604/9e39b980cf30/41598_2021_2773_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a45/8636604/4f94b8f503ac/41598_2021_2773_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a45/8636604/69ab5fde9e6a/41598_2021_2773_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a45/8636604/e044502cc340/41598_2021_2773_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a45/8636604/1a4ae0e50e56/41598_2021_2773_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a45/8636604/0fbb656c9dcb/41598_2021_2773_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a45/8636604/b747293057c2/41598_2021_2773_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a45/8636604/c4d618c50100/41598_2021_2773_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a45/8636604/9e39b980cf30/41598_2021_2773_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a45/8636604/4f94b8f503ac/41598_2021_2773_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a45/8636604/69ab5fde9e6a/41598_2021_2773_Fig8_HTML.jpg

相似文献

1
Pan-cancer analysis of non-oncogene addiction to DNA repair.多癌种分析非致癌基因对 DNA 修复的依赖性。
Sci Rep. 2021 Dec 1;11(1):23264. doi: 10.1038/s41598-021-02773-3.
2
Targeting Non-Oncogene Addiction for Cancer Therapy.针对癌症治疗的非癌基因成瘾。
Biomolecules. 2021 Jan 20;11(2):129. doi: 10.3390/biom11020129.
3
Oncogenic mutation or overexpression of oncogenic KRAS or BRAF is not sufficient to confer oncogene addiction.致癌基因突变或过表达的致癌 KRAS 或 BRAF 不足以赋予致癌基因成瘾性。
PLoS One. 2021 Apr 1;16(4):e0249388. doi: 10.1371/journal.pone.0249388. eCollection 2021.
4
Promoter methylation of DNA damage repair (DDR) genes in human tumor entities: / is almost exclusively methylated in bladder cancer.人类肿瘤实体中 DNA 损伤修复 (DDR) 基因的启动子甲基化:/ 在膀胱癌中几乎完全甲基化。
Clin Epigenetics. 2018 Feb 6;10:15. doi: 10.1186/s13148-018-0447-6. eCollection 2018.
5
Noncoding RNAs in DNA Damage Response: Opportunities for Cancer Therapeutics.DNA损伤反应中的非编码RNA:癌症治疗的机遇
Methods Mol Biol. 2018;1699:3-21. doi: 10.1007/978-1-4939-7435-1_1.
6
Copy Number Amplification of DNA Damage Repair Pathways Potentiates Therapeutic Resistance in Cancer.DNA 损伤修复途径的拷贝数扩增增强了癌症的治疗抵抗性。
Theranostics. 2020 Mar 4;10(9):3939-3951. doi: 10.7150/thno.39341. eCollection 2020.
7
Patient-Level DNA Damage and Repair Pathway Profiles and Prognosis After Prostatectomy for High-Risk Prostate Cancer.高危前列腺癌前列腺切除术后患者的 DNA 损伤和修复途径特征与预后。
JAMA Oncol. 2016 Apr;2(4):471-80. doi: 10.1001/jamaoncol.2015.4955.
8
Identification of hyper-rewired genomic stress non-oncogene addiction genes across 15 cancer types.鉴定 15 种癌症类型中超重布线基因组应激非致癌基因成瘾基因。
NPJ Syst Biol Appl. 2019 Aug 7;5:27. doi: 10.1038/s41540-019-0104-5. eCollection 2019.
9
Genomic alterations underlie a pan-cancer metabolic shift associated with tumour hypoxia.基因组改变是与肿瘤缺氧相关的泛癌代谢转变的基础。
Genome Biol. 2016 Jun 29;17(1):140. doi: 10.1186/s13059-016-0999-8.
10
Identification of DNA Damage Repair-Associated Prognostic Biomarkers for Prostate Cancer Using Transcriptomic Data Analysis.基于转录组数据分析鉴定前列腺癌相关 DNA 损伤修复预后生物标志物
Int J Mol Sci. 2021 Oct 29;22(21):11771. doi: 10.3390/ijms222111771.

引用本文的文献

1
Comprehensive analysis of RFC4 as a potential biomarker for regulating the immune microenvironment and predicting immune therapy response in lung adenocarcinoma.对RFC4作为调节肺腺癌免疫微环境和预测免疫治疗反应的潜在生物标志物的综合分析。
Front Immunol. 2025 Jun 19;16:1578243. doi: 10.3389/fimmu.2025.1578243. eCollection 2025.
2
Analysis of the correlation between RFC4 expression and tumor immune microenvironment and prognosis in patients with cervical cancer.宫颈癌患者中RFC4表达与肿瘤免疫微环境及预后的相关性分析。
Front Genet. 2025 May 19;16:1514383. doi: 10.3389/fgene.2025.1514383. eCollection 2025.
3

本文引用的文献

1
A first-in-class Polymerase Theta Inhibitor selectively targets Homologous-Recombination-Deficient Tumors.一种一流的聚合酶θ抑制剂选择性靶向同源重组缺陷型肿瘤。
Nat Cancer. 2021 Jun;2(6):598-610. doi: 10.1038/s43018-021-00203-x. Epub 2021 Jun 17.
2
Polθ inhibitors elicit BRCA-gene synthetic lethality and target PARP inhibitor resistance.聚(ADP-核糖)聚合酶抑制剂能引发 BRCA 基因合成致死,并靶向聚 ADP 核糖聚合酶抑制剂耐药性。
Nat Commun. 2021 Jun 17;12(1):3636. doi: 10.1038/s41467-021-23463-8.
3
Targeting POLE2 Creates a Novel Vulnerability in Renal Cell Carcinoma via Modulating Stanniocalcin 1.
Dynamic interplay of cNHEJ and MMEJ pathways of DNA double-strand break repair during embryonic development in zebrafish.
斑马鱼胚胎发育过程中DNA双链断裂修复的经典非同源末端连接和微同源性介导的末端连接途径的动态相互作用
Sci Rep. 2025 Feb 10;15(1):4886. doi: 10.1038/s41598-025-88564-6.
4
Targeting DNA Damage Response Deficiency in Thoracic Cancers.针对胸部癌症中的 DNA 损伤反应缺陷。
Drugs. 2024 Sep;84(9):1025-1033. doi: 10.1007/s40265-024-02066-9. Epub 2024 Jul 13.
5
The biological significance of cuproptosis-key gene MTF1 in pan-cancer and its inhibitory effects on ROS-mediated cell death of liver hepatocellular carcinoma.铜死亡关键基因MTF1在泛癌中的生物学意义及其对活性氧介导的肝细胞癌细胞死亡的抑制作用。
Discov Oncol. 2023 Jun 28;14(1):113. doi: 10.1007/s12672-023-00738-8.
6
Reuniting philosophy and science to advance cancer research.将哲学与科学重新结合起来,以推进癌症研究。
Biol Rev Camb Philos Soc. 2023 Oct;98(5):1668-1686. doi: 10.1111/brv.12971. Epub 2023 May 8.
7
Pan-Cancer Analysis on the Oncogenic Role of Programmed Cell Death 10.程序性细胞死亡蛋白10致癌作用的泛癌分析
J Oncol. 2022 Oct 13;2022:1242658. doi: 10.1155/2022/1242658. eCollection 2022.
8
Exonucleases: Degrading DNA to Deal with Genome Damage, Cell Death, Inflammation and Cancer.核酸外切酶:降解 DNA 以应对基因组损伤、细胞死亡、炎症和癌症。
Cells. 2022 Jul 9;11(14):2157. doi: 10.3390/cells11142157.
9
EF-Hand Domain-Containing Protein D2 (EFHD2) Correlates with Immune Infiltration and Predicts the Prognosis of Patients: A Pan-Cancer Analysis.EF 手结构域蛋白 D2(EFHD2)与免疫浸润相关,并预测患者的预后:泛癌症分析。
Comput Math Methods Med. 2022 Mar 15;2022:4878378. doi: 10.1155/2022/4878378. eCollection 2022.
靶向POLE2通过调节鲎素1在肾细胞癌中产生新的脆弱性。
Front Cell Dev Biol. 2021 Feb 11;9:622344. doi: 10.3389/fcell.2021.622344. eCollection 2021.
4
shinyDepMap, a tool to identify targetable cancer genes and their functional connections from Cancer Dependency Map data.shinyDepMap,一个从癌症基因依赖图谱数据库中识别潜在癌症基因及其功能关联的工具。
Elife. 2021 Feb 8;10:e57116. doi: 10.7554/eLife.57116.
5
POLE2 knockdown reduce tumorigenesis in esophageal squamous cells.POLE2基因敲低可降低食管鳞状细胞的肿瘤发生。
Cancer Cell Int. 2020 Aug 11;20:388. doi: 10.1186/s12935-020-01477-4. eCollection 2020.
6
Impact of DNA damage repair defects on response to radium-223 and overall survival in metastatic castration-resistant prostate cancer.DNA 损伤修复缺陷对镭-223 治疗转移性去势抵抗性前列腺癌及总生存的影响。
Eur J Cancer. 2020 Sep;136:16-24. doi: 10.1016/j.ejca.2020.05.001. Epub 2020 Jul 4.
7
Drug mechanism-of-action discovery through the integration of pharmacological and CRISPR screens.通过药理学和 CRISPR 筛选的整合发现药物作用机制。
Mol Syst Biol. 2020 Jul;16(7):e9405. doi: 10.15252/msb.20199405.
8
Molecular Targeting of Cancer-Associated PCNA Interactions in Pancreatic Ductal Adenocarcinoma Using a Cell-Penetrating Peptide.使用细胞穿透肽对胰腺导管腺癌中与癌症相关的增殖细胞核抗原相互作用进行分子靶向
Mol Ther Oncolytics. 2020 Apr 8;17:250-256. doi: 10.1016/j.omto.2020.03.025. eCollection 2020 Jun 26.
9
Copy Number Amplification of DNA Damage Repair Pathways Potentiates Therapeutic Resistance in Cancer.DNA 损伤修复途径的拷贝数扩增增强了癌症的治疗抵抗性。
Theranostics. 2020 Mar 4;10(9):3939-3951. doi: 10.7150/thno.39341. eCollection 2020.
10
CHK1 Inhibition Is Synthetically Lethal with Loss of B-Family DNA Polymerase Function in Human Lung and Colorectal Cancer Cells.CHK1 抑制与 B 族 DNA 聚合酶功能丧失在人肺癌和结直肠癌细胞中协同致死。
Cancer Res. 2020 Apr 15;80(8):1735-1747. doi: 10.1158/0008-5472.CAN-19-1372. Epub 2020 Mar 11.